mTOR pathway and DNA damage response: A therapeutic strategy in cancer therapy.

DNA Repair
Romina Danesh PazhoohHamed Mirzaei

Abstract

The mammalian target of rapamycin (mTOR) is a conserved serine/threonine-protein kinase, comprising two subunit protein complexes: mTORC1 and mTORC2. In response to insult and cancer, the mTOR pathway plays a crucial role in regulating growth, metabolism, cell survival, and protein synthesis. Key subunits of mTORC1/2 catalyze the phosphorylation of various molecules, including eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), ribosomal protein S6 kinase β-1 (S6K1). The DNA damage response (DDR) maintains genomic stability and provides an opportunity for treating tumors with defects caused by DNA damaging agents. Many mTOR inhibitors are utilized for the treatment of cancers. However, several clinical trials are still assessing the efficacy of mTOR inhibitors. This paper discusses the role of the mTOR signaling pathway and its regulators in developing cancer. In the following, we will review the interaction between DDR and mTOR signaling and the innovative therapies applied in preclinical and clinical trials for treating cancers.

References

Feb 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·W K Kaufmann, R S Paules
Aug 8, 1997·The Journal of Biological Chemistry·K B Beckman, B N Ames
May 18, 2001·Nature·J H Hoeijmakers
Jan 19, 2002·The Journal of Biological Chemistry·Terence P HerbertChristopher G Proud
Aug 13, 2002·Nature Cell Biology·Ken InokiKun-Liang Guan
Jan 14, 2003·The Journal of Biological Chemistry·Kristina S KovacinaRichard A Roth
Jan 31, 2003·Nature·Christopher J Bakkenist, Michael B Kastan
Feb 24, 1956·Science·O WARBURG
Nov 18, 2003·Molecular Biology of the Cell·Almudena PorrasAngel R Nebreda
Jan 13, 2004·World Journal of Gastroenterology : WJG·Jun YangYing-Nian Yu
Apr 3, 2004·Free Radical Biology & Medicine·Qihe XuMasanori Kitamura
Apr 13, 2004·Oncogene·Teiji Wada, Josef M Penninger
Jul 29, 2004·DNA Repair·Ari Barzilai, Ken-Ichi Yamamoto
Sep 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Philippe P RouxJohn Blenis
Sep 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L A DeGraffenriedM Hidalgo
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wallace H MondesireFunda Meric-Bernstam
Nov 19, 2004·Nature·Michael B Kastan, Jiri Bartek
Feb 19, 2005·Science·D D SarbassovDavid M Sabatini
May 10, 2005·Science·Samuel E SchrinerPeter S Rabinovitch
Dec 13, 2005·Nature Reviews. Drug Discovery·Bryan T HennessyGordon B Mills
Dec 13, 2005·Nature Reviews. Cancer·Andreas G BaderPeter K Vogt
May 26, 2006·Nature·Reuben J Shaw, Lewis C Cantley
Aug 3, 2006·Nature Reviews. Drug Discovery·Sandrine FaivreEric Raymond
Oct 17, 2006·Oncogene·Y MamaneN Sonenberg
Oct 17, 2006·Oncogene·J Averous, C G Proud
Feb 6, 2007·Nature Cell Biology·Emilie Vander HaarDo-Hyung Kim
Mar 10, 2007·American Journal of Obstetrics and Gynecology·Michael R MilamKaren H Lu
Mar 28, 2007·Molecular Cell·Yasemin SancakDavid M Sabatini
May 15, 2007·Oncogene·M M McKay, D K Morrison
May 17, 2007·Apoptosis : an International Journal on Programmed Cell Death·Paloma BragadoAlmudena Porras
Jun 22, 2007·Nature·Sheila S DavidSucharita Kundu
Jul 7, 2007·Cancer Cell·David A Guertin, David M Sabatini
Sep 6, 2007·Journal of Cellular Physiology·Enrique Rozengurt
Nov 22, 2007·PloS One·Kathrin ThedieckMichael N Hall
Dec 18, 2007·Molecular Cell·J Wade Harper, Stephen J Elledge
Jan 8, 2008·Cell Metabolism·Ralph J DeBerardinisCraig B Thompson
Jan 22, 2008·Biochimica Et Biophysica Acta·Atsushi Matsuzawa, Hidenori Ichijo
Jul 25, 2008·Proceedings of the National Academy of Sciences of the United States of America·Denis M Schewe, Julio A Aguirre-Ghiso
Aug 5, 2008·Cancer Research·Katherine Stemke-HaleBryan T Hennessy
Oct 25, 2008·Nature·Li DingRichard K Wilson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Hematology & Oncology
Hui HuaYangfu Jiang
F1000Research
Jianling XieChristopher G Proud
Anti-cancer Agents in Medicinal Chemistry
Hongyu ZhouShile Huang
BMB Reports
Seo-Kyoung Hwang, Hyung-Hwan Kim
© 2021 Meta ULC. All rights reserved